AdaptHealth (AHCO) Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024 summary

Leadership perspectives and strategic focus

• New CEO brings extensive healthcare, legal, and public health experience, emphasizing the opportunity in at-home care due to an aging population and the need to decentralize healthcare.

• A five-point action plan is underway: organizational clarity, organic growth, balance sheet optimization, innovation, and automation/AI.

• Leadership team expansion and role clarity are priorities, with ongoing recruitment and standardization of processes across locations.

• Standard work protocols and KPIs are being implemented to unify operations under the "One Adapt" initiative through 2024.

Operational and financial highlights

• Second quarter results exceeded expectations, with diabetes CGM business performing as anticipated and respiratory segment gaining market share.

• Sleep segment showed sequential growth, and resupply remains a strong revenue engine.

• Full-year guidance was reiterated, with cost-out efforts in Q3 expected to fund new investments in talent and technology.

• Free cash flow guidance was raised, and leverage is targeted to decrease to mid-2x range, with proceeds from non-core asset sales directed to deleveraging.

Market and growth strategies

• Commercial focus is shifting to national and enterprise accounts, with new leadership hired to drive large-scale partnerships.

• Payer engagement and clinical relevance are being strengthened, supported by a new VP of Innovation and Chief Medical Officer.

• Automation and AI pilots are underway in clinical documentation and intake, aiming to improve efficiency and order conversion rates.